Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.330 USD | +0.23% | +0.70% | -1.37% |
07-26 | Neuberger Berman Investment Advisers Engages in Discussions with E2open Parent Holdings | CI |
07-11 | Goldman Sachs Trims Price Target on E2open Parent to $4 From $4.50, Maintains Neutral Rating | MT |
Fiscal Period: February | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
Revenues | - | 256M | 426M | 652M | 635M |
Total Revenues | - | 256M | 426M | 652M | 635M |
Cost of Goods Sold, Total | - | 144M | 148M | 221M | 215M |
Gross Profit | - | 112M | 278M | 431M | 420M |
Selling General & Admin Expenses, Total | 3.89M | 383M | 130M | 172M | 177M |
R&D Expenses | - | 125M | 79.7M | 97.98M | 101M |
Amortization of Goodwill and Intangible Assets - (IS) | - | 63.43M | 120M | 181M | 179M |
Other Operating Expenses, Total | 3.89M | 572M | 330M | 451M | 458M |
Operating Income | -3.89M | -460M | -52.05M | -19.94M | -37.78M |
Interest Expense, Total | - | -23.14M | -33.66M | -76.83M | -102M |
Interest And Investment Income | 49.53K | - | - | - | - |
Net Interest Expenses | 49.53K | -23.14M | -33.66M | -76.83M | -102M |
Other Non Operating Income (Expenses) | - | 278M | 1.48M | 34.64M | 17.09M |
EBT, Excl. Unusual Items | -3.84M | -205M | -84.23M | -62.14M | -123M |
Merger & Related Restructuring Charges | - | -51.8M | -64.36M | -16.3M | -2.08M |
Impairment of Goodwill | - | - | - | -902M | -1.1B |
Asset Writedown | - | - | - | -4.14M | -34.66M |
Legal Settlements | - | - | - | - | -17.75M |
Other Unusual Items | - | 404M | -71.37M | 13.56M | 7.92M |
EBT, Incl. Unusual Items | -3.84M | 147M | -220M | -971M | -1.27B |
Income Tax Expense | - | -7.34M | -30.05M | -250M | -82.38M |
Earnings From Continuing Operations | -3.84M | 154M | -190M | -720M | -1.19B |
Net Income to Company | -3.84M | 154M | -190M | -720M | -1.19B |
Minority Interest | - | -24.68M | 24.14M | 71.5M | 115M |
Net Income - (IS) | -3.84M | 130M | -166M | -649M | -1.07B |
Net Income to Common Incl Extra Items | -3.84M | 130M | -166M | -649M | -1.07B |
Net Income to Common Excl. Extra Items | -3.84M | 130M | -166M | -649M | -1.07B |
Per Share Items | |||||
Net EPS - Basic | -0.07 | 0.69 | -0.68 | -2.15 | -3.52 |
Basic EPS - Continuing Operations | -0.07 | 0.69 | -0.68 | -2.15 | -3.52 |
Basic Weighted Average Shares Outstanding | 56.75M | 187M | 245M | 302M | 304M |
Net EPS - Diluted | -0.07 | 0.67 | -0.68 | -2.15 | -3.52 |
Diluted EPS - Continuing Operations | -0.07 | 0.67 | -0.68 | -2.15 | -3.52 |
Diluted Weighted Average Shares Outstanding | 56.75M | 223M | 245M | 302M | 304M |
Normalized Basic EPS | -0.04 | -0.82 | -0.12 | 0.11 | 0.13 |
Normalized Diluted EPS | -0.04 | -0.69 | -0.12 | 0.11 | 0.13 |
Supplemental Items | |||||
EBITDA | - | -383M | 90.56M | 188M | 168M |
EBITA | -3.89M | -396M | 68.15M | 161M | 141M |
EBIT | -3.89M | -460M | -52.05M | -19.94M | -37.78M |
EBITDAR | - | -31.33M | 100M | 199M | 178M |
Total Revenues (As Reported) | - | 256M | 426M | 652M | 635M |
Effective Tax Rate - (Ratio) | - | -5 | 13.66 | 25.8 | 6.5 |
Current Domestic Taxes | - | 5.26M | 1.69M | 3.22M | 1.46M |
Current Foreign Taxes | - | 6.94M | 4.01M | 5.84M | 3.95M |
Total Current Taxes | - | 12.19M | 5.69M | 9.05M | 5.41M |
Deferred Domestic Taxes | - | -20.22M | -31.13M | -250M | -78.06M |
Deferred Foreign Taxes | - | 684K | -4.61M | -9.67M | -9.72M |
Total Deferred Taxes | - | -19.54M | -35.74M | -259M | -87.79M |
Normalized Net Income | -2.4M | -153M | -28.51M | 32.66M | 38.09M |
Interest on Long-Term Debt | - | - | 569K | 212K | 214K |
Supplemental Operating Expense Items | |||||
Advertising Expense | - | - | - | 16.2M | 10.5M |
Selling and Marketing Expenses | - | 105M | 60.26M | 87.96M | 87.73M |
General and Administrative Expenses | 3.89M | 277M | 69.92M | 83.93M | 89.64M |
Research And Development Expense From Footnotes | - | 125M | 79.7M | 97.98M | 101M |
Net Rental Expense, Total | - | 600K | 9.46M | 11.63M | 10.01M |
Imputed Operating Lease Interest Expense | - | - | 3.39M | 6.92M | 7.6M |
Imputed Operating Lease Depreciation | - | - | 6.07M | 4.72M | 2.41M |
Stock-Based Comp., COGS (Total) | - | 38.98M | 1.09M | 1.47M | 4.26M |
Stock-Based Comp., R&D Exp. (Total) | - | 62.69M | 1.77M | 3.08M | 5.68M |
Stock-Based Comp., S&M Exp. (Total) | - | 61.61M | 1.57M | 3.3M | 5.69M |
Stock-Based Comp., G&A Exp. (Total) | - | 233M | 6.21M | 9.71M | 11.54M |
Total Stock-Based Compensation | - | 396M | 10.64M | 17.56M | 27.17M |